Vanguard Health Care ETF (NY:VHT)

311.90 +0.18 (+0.06%)

Official Closing Price Updated: 8:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vanguard Health Care ETF

< Previous 1 2 3 4 5 Next >

TLRY Stock In Focus After Alliance Global Halves Price Target ↗

January 09, 2026

Alliance Global cut TLRY’s target price to $10 from $20, citing limited visibility into the company’s long-term sales trajectory and cash flow.

Via Stocktwits

Topics Cannabis

MLTX Stock Extends Rally As FDA Feedback Spurs Bullish Brokerage Action – Retail Speculates On Potential M&A Conversations ↗

January 09, 2026

Via Stocktwits

Why Did CRMD Stock Crash 28% Today? ↗

January 08, 2026

CorMedix announced that for 2026, it expects revenue between $300 million and $320 million, compared to $310 million it reported in the full year 2025, according to preliminary data.

Via Stocktwits

Why Did MLTX Stock Jump 45% In Pre-Market Today? ↗

January 08, 2026

The company said it received positive regulatory feedback from the U.S. FDA following a Type B meeting regarding a drug used to treat hidradenitis suppurativa, a chronic inflammatory skin disorder.

Via Stocktwits

Hedge Funds Snap Up Eli Lilly, United Healthcare, And More, Putting Healthcare ETFs Back In The Spotlight ↗

November 17, 2025

With funds buying Eli Lilly, UNH, and other pharma giants, healthcare ETFs can emerge as key beneficiaries of a broader defensive rotation.

Via Benzinga

Topics ETFs

SNDX Stock Is The Talk Of The Town Today: Here’s Everything To Know About The Latest FDA Approval ↗

October 24, 2025

Via Stocktwits

Neumora Therapeutics’ Experimental Drug Demonstrates Weight Loss in Preclinical Studies ↗

October 27, 2025

Neumora said that NMRA-215 demonstrated weight loss of up to 19% as a monotherapy and 26% in combination with Semaglutide.

Via Stocktwits

How Trump's Shutdown Standoff Could Hand Health-Care ETFs A Lifeline ↗

October 07, 2025

Trump's comments on health-care negotiations with Democrats can put ETFs like XLV, IHF, and XHS back on investors' radar as Washington's shutdown drags on.

Via Benzinga

Topics ETFs Government

The Healthcare Stock Play That Could Make Millennials Rich ↗

October 06, 2025

This investment may also make baby boomers, and those from Gen X and Gen Z, rich as well.

Via The Motley Fool

Topics ETFs

Trump Admin Targets Medicaid Spending On Immigrants, Threatening Over $12 Billion California Program ↗

September 06, 2025

The Trump administration is investigating Medicaid spending in California and other Democrat-led states over potential misuse in immigrant healthcare programs.

Via Benzinga

Topics Government

Trump-nominee Susan Monarez Confirmed As CDC Director By Senate ↗

July 30, 2025

According to a report by Reuters, the Senate voted 51-47 along party lines to confirm the President’s nominee.

Via Stocktwits

Topics Government Workforce

Here's Why Vanguard's Worst-Performing Sector ETF Is a No-Brainer Buy Right Now ↗

July 21, 2025

Via The Motley Fool

Topics Artificial Intelligence ETFs

US Supreme Court Reportedly Upholds Part Of Obamacare That Guarantees Health Insurers Cover Preventive Care ↗

June 27, 2025

The Obamacare law requires health insurers to provide preventive care, including cancer screenings and HIV prevention medication, at no cost to patients.

Via Stocktwits

Topics Government Lawsuit Religion

UnitedHealth Reportedly Draws Bids Worth $1B For Banmedica In Latin America Exit ↗

June 09, 2025

According to Reuters, UnitedHealth has received four preliminary bids for Banmedica and could set a deadline for binding offers as early as July.

Via Stocktwits

Topics Fraud

Regeneron Stock Drops On Mixed Results For Smoker’s Lung Treatment ↗

May 30, 2025

Both trials were conducted during the COVID-19 pandemic, a factor the companies said may have influenced the outcomes.

Via Stocktwits

Topics Government Stocks

Merus Stock Soars On Positive Phase 2 Drug Trial Data, Price Target Hikes: Retail’s Thrilled ↗

May 23, 2025

BofA’s new price target of $92 implies a 121% upside to Merus’s closing share price of $41.6 on Thursday.

Via Stocktwits

Creating A Sector-Based ETF Portfolio ↗

April 19, 2025

A sector-based ETF portfolio provides an effective way to navigate these market rhythms, allowing investors to position their assets for potential outperformance.

Via Talk Markets

Topics ETFs

RFK Jr.'s Massive Federal Health Workforce Cut Could Take 'Decades To Rebuild,' Warn Experts: 'We Cannot Accurately Assess Whether We Are Truly Making America Healthier' ↗

April 14, 2025

Experts raise alarms about Health Secretary Robert F. Kennedy Jr's decision to layoff tens of thousands of federal workers, disrupting critical health data collection and research efforts.

Via Benzinga

Topics Workforce

As Trump Tariffs Spark Panic, Investors Rush Into These 5 'Recession-Proof' ETFs ↗

April 08, 2025

ETFs that provide exposure to sectors that have historically been considered defensive during downturns are now in the limelight.

Via Benzinga

Topics ETFs Government

Best Blue-Chip ETFs To Buy As Donald Trump’s Trade War Escalates ↗

March 30, 2025

Investing in defensive ETFs may be a good way to weather the storm.

Via Talk Markets

Topics ETFs Government World Trade

Investors Are Flocking to These 3 Vanguard Sector ETFs. Should You Buy Them Too? ↗

March 28, 2025

Via The Motley Fool

Topics ETFs Economy Government

Lifeline For 23andMe? Stock Jumps After Court Greenlights Bankruptcy Asset Sale, Retail Weighs Possible Rescue Deals ↗

March 28, 2025

Stocktwits users spotted a media report about Richard Magides, the director of Singapore-based Zentree Investment and 23andMe's second-largest shareholder, expressing interest in backing a rescue...

Via Stocktwits

Topics Bankruptcy

HealthEquity Stock Sees Biggest Drop In Over 3 Years On Disappointing Outlook — Retail Doesn't Feel It's All Doom And Gloom ↗

March 20, 2025

CFO James Lucania said on the earnings call that fraud prevention efforts are ongoing, and service expenses are expected to remain elevated through the first half of fiscal 2026.

Via Stocktwits

Topics Earnings Fraud

Trump Tariffs and the Nasdaq Correction Have Been No Match for These Stock Market Sectors ↗

March 17, 2025

Via The Motley Fool

Topics Government

Healthcare Sector Trying To Bounce Back ↗

March 09, 2025

I often discuss highly rated stocks that are part of highly rated sectors. Thus, this time is a departure from the norm. Let's dive into the data for the healthcare sector.

Via Talk Markets

Topics ETFs Stocks / Equities

Ocugen Stock Lifts Retail Investor Confidence As Q4 Revenue Crushes Estimates ↗

March 05, 2025

Watchers on Stocktwits expressed optimism about the company’s pipeline and its aim to secure three BLAs over the next three years.

Via Stocktwits

Is It Time To Shift Focus To Beaten-Down Healthcare Stocks As Volatility Soars? ↗

March 04, 2025

Healthcare performed terribly in 2023 and 2024, falling while the market was soaring. Year-to-date, the sector has outperformed. Is it time to focus on the stocks and ETFs of this low-Beta sector as...

Via Talk Markets

Topics ETFs Stocks / Equities

These Vanguard ETFs Show Where the Smart Money Is Moving Now ↗

March 03, 2025

Via The Motley Fool

Topics ETFs

Prediction: 2 Brilliant Vanguard Index Funds Will Continue to Beat the S&P 500 in 2025 ↗

March 02, 2025

Via The Motley Fool

Topics Stocks

Hims & Hers Stock Sinks After-Hours As Weight-Loss Roadmap Gets Clouded — Retail Pounces On The Dip ↗

February 24, 2025

On the earnings call, CEO Andrew Dudum acknowledged that the transition would be "inevitable" for patients currently on compounded semaglutide.

Via Stocktwits

Topics Earnings

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.